Clinical Trials on Respiratory Viral Infections in China

Total 7444 results

The University of Hong Kong

Active, not recruiting

Covid-19 Vaccination in Adolescents and Children (COVAC)

Covid19

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated (COVID-19)

Covid19

China
WestVac Biopharma Co., Ltd.
WestVac Biopharma (Guangzhou) Co., Ltd.

Recruiting

A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

COVID-19

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Hunan Provincial Center for Disease Control and Prevention; Guizhou Center... and other collaborators

Recruiting

Safety Study of COVID19 Vaccine on the Market

COVID-19

China
Zhongnan Hospital
Institute of Biotechnology, Academy of Military Medical Sciences, PLA of...

Recruiting

A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes

COVID-19

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Study of HS-10517 in Chinese Adult Participants

COVID-19

China
Hebei Medical University

Recruiting

Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection

COVID-19

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

SARS-CoV-2 Infection Among Healthcare Workers

COVID-19

China
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

COVID-19

China
AstraZeneca

Completed

Study on Determine the Utilisation and Clinical Outcomes of Evusheld in COVID-19 PrEP in China (CLEAR)

COVID-19

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Withdrawn

Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) (COVID-19)

COVID-19 | Pneumonia

China
Affiliated Hospital of Yunnan University
Kunming Medical University; Yunnan University

Completed

A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults

COVID-19

China
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

COVID-19

China
Institute of Medical Biology, Chinese Academy of...
West China Second University Hospital; Yunnan Center for Disease Control and...

Completed

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

COVID-19

China
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Withdrawn

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

COVID-19

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Active, not recruiting

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

COVID-19

China
Institute of Biotechnology, Academy of Military...
Zhongnan Hospital

Completed

A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults

COVID-19

China
Brii Biosciences, Inc.

Withdrawn

A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Completed

Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly

COVID-19

China
Sinovac Research and Development Co., Ltd.

Suspended

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

COVID-19

China
Jiangsu Province Centers for Disease Control and...
West China Hospital

Completed

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Beijing Minhai Biotechnology Co., Ltd
Shenzhen Kangtai Biological Products Co., LTD; Jiangsu Province Centers for...

Unknown

A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

COVID-19

China
Jiangsu Famous Medical Technology Co., Ltd.

Completed

TCM Differentiation and Treatment Protocol of COVID-19 (TDATPOC)

COVID-19

China
The First Affiliated Hospital of Guangzhou Medical...

Withdrawn

Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19

COVID-19

China
Chinese Alliance Against Lung Cancer
Shanghai Respiratory Research Institution

Unknown

The COVID-19 Mobile Health Study (CMHS) (CMHS)

COVID-19

China
Fujian Medical University Union Hospital

Active, not recruiting

Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection

COVID-19 | Postoperative Complications | Breast Cancer

China
Ruijin Hospital

Recruiting

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

COVID-19 Pneumonia

China
Shanghai Vinnerna Biosciences Co., Ltd.

Recruiting

A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

COVID-19 Patient

China
Xinqiao Hospital of Chongqing

Completed

A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease

COVID-19 Disease

China
Capital Medical University

Active, not recruiting

Pirfenidone in Adult Hospitalized Patients With COVID-19

COVID-19 Pneumonia

China
Frontier Biotechnologies Inc.

Completed

A Study of FB2001 for Inhalation in Healthy Chinese Adults

COVID-19 Pandemic

China
Sinovac Biotech Co., Ltd

Completed

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

COVID-19

China
Sinovac Life Sciences Co., Ltd.

Active, not recruiting

Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine

COVID-19

China
The University of Hong Kong
Hong Kong Council on Smoking and Health

Completed

COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via "Quit to Win" Contest 2020 (QTW2020)

Smoking Cessation

China
ZhiYong Peng

Terminated

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

Pneumonia, Viral | Pneumonia, Ventilator-Associated | Vitamin C

China
Shanghai East Hospital

Recruiting

UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients

COVID-19 Pneumonia | Mesenchymal Stem Cell

China
First Affiliated Hospital of Fujian Medical University

Withdrawn

Fingolimod in COVID-19

Coronavirus Disease (COVID-19)

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Active, not recruiting

Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT

COVID-19 | Respiratory Function | PET/CT | Inflammatory Lesions

China
Qilu Hospital of Shandong University

Recruiting

A Follow-up Study of Immune Dysregulation in Patients With COVID-19

COVID-19 | Immunosuppression

China
Qin Ning
Xiangya Hospital of Central South University; First Affiliated Hospital Xi'an... and other collaborators

Recruiting

Follow-up Study of Population Vaccinated With COVID-19 Vaccine

Healthy

China
The First Affiliated Hospital of Zhengzhou University
Luoyang Central Hospital; Nanyang Central Hospital; The Fifth People's Hospital... and other collaborators

Completed

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

COVID-19 | Azvudine

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

COVID-19

China
Chinese Medical Association

Completed

The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 (BOIFIM)

COVID-19 | Berberine

China
Ruijin Hospital

Recruiting

A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai

COVID-19

China
National Drug Clinical Trial Institute of the Second...
Therorna

Recruiting

A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

COVID-19 | COVID-19 Immunisation

China
Qianfoshan Hospital

Recruiting

Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19

COVID-19 Pneumonia

China

Clinical Trials on Respiratory Viral Infections in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations